Search

Author/Creator Marano, Luana

2. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Issue 5 (May 2021)

Authors:
Risitano, Antonio M; Röth, Alexander; Soret, Juliette; Frieri, Camilla; de Fontbrune, Flore Sicre; Marano, Luana; Alashkar, Ferras; Benajiba, Lina; Marotta, Serena; Rozenberg, Izabela; Milojevic, Julie; End, Peter; Nidamarthy, Prasanna K; Junge, Guido; Peffault de Latour, Régis
Journal:
Lancet
Issue:
Volume 8:Issue 5(2021)
Page Start:
e344
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Secondary syphilis mimicking malignancy: A case report and review of literature. Issue 8 (August 2017)

Authors:
Cerchione, Claudio; Maraolo, Alberto Enrico; Marano, Luana; Pugliese, Novella; Nappi, Davide; Tosone, Grazia; Cimmino, Ilaria; Cozzolino, Imma; Martinelli, Vincenzo; Pane, Fabrizio; Picardi, Marco
Journal:
Journal of infection and chemotherapy
Issue:
Volume 23:Issue 8(2017:Aug.)
Page Start:
576
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The long‐acting anti‐C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab. (19th January 2023)

Authors:
Sica, Michela; Barone, Federica; Nannelli, Caterina; Ricci, Patrizia; Marano, Luana; De Angioletti, Maria; Di Bona, Eros; Risitano, Antonio M.; Notaro, Rosario
Journal:
British journal of haematology
Issue:
Volume 201:Number 1(2023)
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗